Theratechnologies R&D spend
Theratechnologies Inc. · TH (TSX) · Montreal, QC · Pharmaceuticals
Latest R&D (CAD)
$23.2M
Period ended 2024-11-30
Revenue (CAD)
$117.6M
19.8% of revenue · scale $52.3M
R&D by fiscal period
2024
$23.2M
2023
$41.0M
| Period end | R&D (CAD) | Revenue (CAD) | Native R&D | Form | Source |
|---|---|---|---|---|---|
| 2024-11-30 | $23,249,615 | $117,619,247 | $16,973,000 USD | Annual financial statements | Annual report |
| 2023-11-30 | $40,990,389 | $110,356,871 | $30,370,000 USD | Annual financial statements | Annual report |
R&D net of tax credits.